Table 2 Patient characteristics, n = 18
n (%) | |
|---|---|
Age | |
Median | 57.5 years |
Range | 41 – 73 years |
Sex | |
Male | 10 (56 %) |
Female | 8 (44 %) |
0 | 8 (44 %) |
1 | 10 (56 %) |
Pancreatic tumor location | |
Head | 11 (61 %) |
Uncinate process | 3 (17 %) |
Body | 2 (11 %) |
Tail | 2 (11 %) |
Biliary stent | |
Yes | 9 (50 %) |
No | 9 (50 %) |
Serum bilirubin level prior to chemotherapy | |
Median | 0.35 mg/dl |
Range | 0.1 – 1.2 mg/dl |
Basis for unresectability | |
Borderline resectable | |
SMV encased (short segment) | 3 (17 %) |
SV encased | 1 (6 %) |
SMV encased (long segment) | 1 (6 %) |
SMA encased | 3 (17 %) |
HA encased | 2 (11 %) |
Celiac trunk encased | 3 (17 %) |
Confluence of PV, SV and SMV encased | 5 (28 %) |